Heart Failure-MRA Safety — EECC MCQ

Instant feedback + full explanation. One question, done properly.

HardCardiologyHeart Failure-MRA SafetyEECC

A recently hospitalised HFrEF patient has haemoglobin 132 g/L, ferritin 82 micrograms/L and transferrin saturation 14%. Which treatment may reduce recurrent HF admissions?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Intravenous iron

HF iron deficiency is present despite normal haemoglobin because ferritin is below 100 and transferrin saturation is low. Intravenous iron can improve functional status and may reduce rehospitalisation after acute HF. Blood loss and other causes require evaluation; oral iron generally has inadequate evidence for this HF outcome. Apply this conclusion only to the clinical circumstances stated, with appropriate specialist review, contraindication checks, shared decision-making and follow-up. Reassess if the physiology, treatment response or competing risk changes. The competing options would require a different haemodynamic profile, diagnosis, procedural indication or risk balance from the one described here.

Reference: 2023 ESC focused update on heart failure. https://www.escardio.org/guidelines/clinical-practice-guidelines/focused-update-on-heart-failure-guidelines/